[C-reactive protein and coronary heart disease: quo vadis?]

MMW Fortschr Med. 2009 Oct:151 Suppl 3:127-32.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Alleles
  • Apolipoproteins E / genetics
  • C-Reactive Protein / genetics
  • C-Reactive Protein / metabolism*
  • Cholesterol, LDL / blood
  • Coronary Artery Disease / drug therapy
  • Coronary Artery Disease / genetics
  • Coronary Artery Disease / immunology*
  • Coronary Artery Disease / prevention & control
  • Female
  • Fluorobenzenes / therapeutic use
  • Haplotypes / genetics
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Male
  • Polymorphism, Genetic / genetics
  • Pyrimidines / therapeutic use
  • Risk Factors
  • Rosuvastatin Calcium
  • Stroke / drug therapy
  • Stroke / genetics
  • Stroke / immunology
  • Stroke / prevention & control
  • Sulfonamides / therapeutic use

Substances

  • Apolipoproteins E
  • Cholesterol, LDL
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides
  • Rosuvastatin Calcium
  • C-Reactive Protein